Annual Operating Profit
$80.96 M
+$78.19 M+2823.80%
December 31, 2022
Summary
- As of February 8, 2025, EGRX annual operating income is $80.96 million, with the most recent change of +$78.19 million (+2823.80%) on December 31, 2022.
- During the last 3 years, EGRX annual operating profit has risen by +$59.15 million (+271.12%).
- EGRX annual operating profit is now at all-time high.
Performance
EGRX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
$10.30 M
-$1.47 M-12.48%
June 30, 2023
Summary
- As of February 8, 2025, EGRX quarterly operating income is $10.30 million, with the most recent change of -$1.47 million (-12.48%) on June 30, 2023.
- Over the past year, EGRX quarterly operating profit has increased by +$8.10 million (+367.73%).
- EGRX quarterly operating profit is now -82.78% below its all-time high of $59.83 million, reached on March 31, 2022.
Performance
EGRX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
$41.01 M
+$8.10 M+24.62%
June 30, 2023
Summary
- As of February 8, 2025, EGRX TTM operating income is $41.01 million, with the most recent change of +$8.10 million (+24.62%) on June 30, 2023.
- Over the past year, EGRX TTM operating profit has dropped by -$16.75 million (-29.00%).
- EGRX TTM operating profit is now -56.08% below its all-time high of $93.37 million, reached on September 30, 2017.
Performance
EGRX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
EGRX Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +2823.8% | +367.7% | -29.0% |
| 3 y3 years | +271.1% | +177.8% | +402.7% |
| 5 y5 years | +7.2% | +8.6% | +88.0% |
EGRX Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +2823.8% | -82.8% | +367.7% | -49.4% | +1380.9% |
| 5 y | 5-year | at high | +2823.8% | -82.8% | +201.3% | -49.4% | +1380.9% |
| alltime | all time | at high | +508.3% | -82.8% | +199.2% | -56.1% | +284.2% |
Eagle Pharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | $10.30 M(-12.5%) | $41.01 M(+24.6%) |
| Mar 2023 | - | $11.77 M(+24.4%) | $32.90 M(-59.4%) |
| Dec 2022 | $80.96 M(+2823.8%) | $9.47 M(+0.0%) | $80.96 M(+4.6%) |
| Sep 2022 | - | $9.46 M(+329.5%) | $77.39 M(+34.0%) |
| Jun 2022 | - | $2.20 M(-96.3%) | $57.75 M(-13.0%) |
| Mar 2022 | - | $59.83 M(+914.2%) | $66.37 M(+2296.9%) |
| Dec 2021 | $2.77 M(-91.6%) | $5.90 M(-158.0%) | $2.77 M(-58.4%) |
| Sep 2021 | - | -$10.18 M(-194.1%) | $6.66 M(-79.3%) |
| Jun 2021 | - | $10.82 M(-386.8%) | $32.26 M(+28.3%) |
| Mar 2021 | - | -$3.77 M(-138.5%) | $25.15 M(-23.7%) |
| Dec 2020 | $32.95 M(+51.1%) | $9.79 M(-36.5%) | $32.95 M(+26.5%) |
| Sep 2020 | - | $15.42 M(+315.7%) | $26.06 M(+219.5%) |
| Jun 2020 | - | $3.71 M(-8.1%) | $8.16 M(-40.4%) |
| Mar 2020 | - | $4.04 M(+39.3%) | $13.68 M(-37.3%) |
| Dec 2019 | $21.82 M(-53.1%) | $2.90 M(-216.6%) | $21.82 M(-37.8%) |
| Sep 2019 | - | -$2.48 M(-126.9%) | $35.08 M(-37.4%) |
| Jun 2019 | - | $9.23 M(-24.1%) | $56.06 M(-0.4%) |
| Mar 2019 | - | $12.17 M(-24.7%) | $56.31 M(+21.2%) |
| Dec 2018 | $46.47 M(-38.5%) | $16.16 M(-12.6%) | $46.45 M(+14.4%) |
| Sep 2018 | - | $18.49 M(+95.0%) | $40.60 M(-15.1%) |
| Jun 2018 | - | $9.48 M(+311.5%) | $47.84 M(+7.1%) |
| Mar 2018 | - | $2.31 M(-77.7%) | $44.68 M(-40.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | $75.50 M(+43.6%) | $10.32 M(-59.9%) | $75.07 M(-19.6%) |
| Sep 2017 | - | $25.73 M(+306.9%) | $93.37 M(+16.5%) |
| Jun 2017 | - | $6.32 M(-80.7%) | $80.18 M(-8.4%) |
| Mar 2017 | - | $32.70 M(+14.3%) | $87.51 M(+67.8%) |
| Dec 2016 | $52.56 M(+1953.0%) | $28.62 M(+128.2%) | $52.16 M(+110.8%) |
| Sep 2016 | - | $12.54 M(-8.2%) | $24.74 M(+1263.9%) |
| Jun 2016 | - | $13.66 M(-615.9%) | $1.81 M(-109.0%) |
| Mar 2016 | - | -$2.65 M(-321.9%) | -$20.18 M(-888.2%) |
| Dec 2015 | $2.56 M(-113.6%) | $1.19 M(-111.5%) | $2.56 M(-149.2%) |
| Sep 2015 | - | -$10.39 M(+24.6%) | -$5.20 M(+32.7%) |
| Jun 2015 | - | -$8.34 M(-141.5%) | -$3.92 M(-372.6%) |
| Mar 2015 | - | $20.09 M(-406.0%) | $1.44 M(-106.5%) |
| Dec 2014 | - | -$6.57 M(-27.9%) | -$22.26 M(+18.7%) |
| Sep 2014 | -$18.76 M(+121.8%) | -$9.11 M(+205.3%) | -$18.76 M(+54.0%) |
| Jun 2014 | - | -$2.98 M(-17.2%) | -$12.18 M(+53.4%) |
| Mar 2014 | - | -$3.60 M(+17.6%) | -$7.94 M(-8.1%) |
| Dec 2013 | - | -$3.06 M(+21.1%) | -$8.64 M(+2.2%) |
| Sep 2013 | -$8.46 M(-57.4%) | -$2.53 M(-300.9%) | -$8.46 M(+42.7%) |
| Jun 2013 | - | $1.26 M(-129.3%) | -$5.92 M(-17.5%) |
| Mar 2013 | - | -$4.31 M(+49.6%) | -$7.18 M(+149.6%) |
| Dec 2012 | - | -$2.88 M | -$2.88 M |
| Sep 2012 | -$19.83 M | - | - |
FAQ
- What is Eagle Pharmaceuticals annual operating income?
- What is the all time high annual operating profit for Eagle Pharmaceuticals?
- What is Eagle Pharmaceuticals annual operating profit year-on-year change?
- What is Eagle Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for Eagle Pharmaceuticals?
- What is Eagle Pharmaceuticals quarterly operating profit year-on-year change?
- What is Eagle Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for Eagle Pharmaceuticals?
- What is Eagle Pharmaceuticals TTM operating profit year-on-year change?
What is Eagle Pharmaceuticals annual operating income?
The current annual operating profit of EGRX is $80.96 M
What is the all time high annual operating profit for Eagle Pharmaceuticals?
Eagle Pharmaceuticals all-time high annual operating income is $80.96 M
What is Eagle Pharmaceuticals annual operating profit year-on-year change?
Over the past year, EGRX annual operating income has changed by +$78.19 M (+2823.80%)
What is Eagle Pharmaceuticals quarterly operating income?
The current quarterly operating profit of EGRX is $10.30 M
What is the all time high quarterly operating profit for Eagle Pharmaceuticals?
Eagle Pharmaceuticals all-time high quarterly operating income is $59.83 M
What is Eagle Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, EGRX quarterly operating income has changed by +$8.10 M (+367.73%)
What is Eagle Pharmaceuticals TTM operating income?
The current TTM operating profit of EGRX is $41.01 M
What is the all time high TTM operating profit for Eagle Pharmaceuticals?
Eagle Pharmaceuticals all-time high TTM operating income is $93.37 M
What is Eagle Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, EGRX TTM operating income has changed by -$16.75 M (-29.00%)